AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Daczim-CL P 50mg/31.25mg Tablet

Prescription Icon
Prescription Required

Marketer

Daksh Pharma Pvt Ltd

Salt Composition

Cefixime (50mg) + Clavulanic Acid (31.25mg)

Overview Daczim-CL P 50mg/31.25mg Tablet

Combiflox-P 50mg/31.25mg tablets are a dual-action antibiotic prescribed for diverse bacterial infections. This medication inhibits bacterial proliferation, thus controlling infection spread. Always follow your doctor's prescription; it can be ingested with or without food, but consistent timing maximizes effectiveness. Never exceed the prescribed dosage; overdosing can be detrimental. If a dose is missed, take it immediately upon recollection. Complete the entire course of treatment, even with symptom improvement; premature cessation can reduce its efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe or persistent side effects require immediate medical attention. Allergic reactions (rash, itching, swelling, breathing difficulties) necessitate immediate medical help. Inform your physician of all current medications before starting this treatment. Pregnant or lactating individuals should consult their doctor. Alcohol consumption should be avoided due to potential increased drowsiness. While it typically doesn't affect driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and hydration are crucial for optimal recovery. Your doctor may order lab tests to monitor the medication's effects.

Primary Ingredients of Daczim-CL P 50mg/31.25mg Tablet

No text was provided. Please provide the text you wish me to rephrase.

Uses of Daczim-CL P 50mg/31.25mg Tablet

Managing bacterial infections

Major Benefits of Daczim-CL P 50mg/31.25mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Daczim-CL P 50mg/31.25mg Tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, however, consistent timing is recommended.

Common Side effects of Daczim-CL P 50mg/31.25mg Tablet:

  • Nausea
  • Diarrhea
  • Stomach pain
  • Indigestion
  • Flatulence

How to use Daczim-CL P 50mg/31.25mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Daczim-CL P 50mg/31.25mg Tablets. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Consumption may coincide with meals or not, but consistency in timing is recommended.

How Daczim-CL P 50mg/31.25mg Tablet works:

Daczim-CL P 50mg/31.25mg tablets contain Cefixime, an antibiotic, and Clavulanic Acid, a beta-lactamase inhibitor. Cefixime's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Clavulanic Acid counteracts bacterial resistance mechanisms, thereby boosting Cefixime's antibacterial effectiveness.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Use of alcohol with Daczim-CL P 50mg/31.25mg tablets requires careful consideration. Physician consultation is recommended.

PregnancyPregnancySAFE IF PRESCRIBED

The use of Daczim-CL P 50mg/31.25mg tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or absent harm to offspring; nevertheless, data from human trials are scarce.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Lactation and the use of Daczim-CL P 50mg/31.25mg tablets are compatible. Research in humans indicates minimal drug transfer to breast milk, posing no discernible risk to the infant.

DrivingDrivingUNSAFE

Driving ability may be impaired by side effects of Daczim-CL P 50mg/31.25mg Tablets, including potential allergic reactions, dizziness, or seizures.

KidneyKidneyCAUTION

Caution is advised when administering Daczim-CL P 50mg/31.25mg tablets to individuals with impaired renal function. Dosage modifications for Daczim-CL P 50mg/31.25mg tablets might be necessary. A physician's guidance is recommended.

LiverLiverCAUTION

Patients with hepatic impairment should use Daczim-CL P 50mg/31.25mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Daczim-CL P 50mg/31.25mg Tablet :

Should you forget a Daczim-CL P 50mg/31.25mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Daczim-CL P 50mg/31.25mg Tablet

LabelValue
Developing Habits No.
Treatment Category Anti-Infective Agents

FAQs on Daczim-CL P 50mg/31.25mg Tablet

Follow your doctor's instructions for taking this medication. It's usually taken once daily by mouth, with or without food. If using chewable tablets, chew them completely before swallowing. Finish all the medication, even if you feel better sooner.
Use Daczim-CL 50mg/31.25mg tablets cautiously in patients with severely impaired kidney function. Adjust the dose for those with moderate or severe renal impairment.
Dosage adjustments for Daczim-CL 50mg/31.25mg tablets are necessary for patients with kidney impairment, gastrointestinal disorders, or colitis.
Daczim-CL 50mg/31.25mg tablets may cause serious side effects, including severe stomach or abdominal pain, persistent nausea or vomiting, fatigue, new infections (like persistent sore throat or fever), jaundice (yellowing of eyes or skin), dark urine, easy bruising or bleeding, kidney problems (altered urination), and mental/mood changes (e.g., confusion).
Before starting this medication, tell your doctor if you're pregnant, breastfeeding, or planning a pregnancy. Also, inform your doctor of any other medications you're taking.
Diarrhea is a possible side effect of Daczim-CL 50mg/31.25mg tablets. This antibiotic targets harmful bacteria, but can also disrupt beneficial gut bacteria, leading to diarrhea. Consult your doctor if you experience severe diarrhea.
Daczim-CL P 50mg/31.25mg Tablets typically begin working quickly, though complete bacterial eradication and symptom relief may take several days.
Contact your doctor if your symptoms worsen during treatment or persist after completing the prescribed course.
Continue taking Daczim-CL 50mg/31.25mg tablets as prescribed, completing the entire course. Even if you feel better, the infection may not be fully eradicated.
Store this medication in its original, tightly closed container, following the label's instructions. Discard any unused medication and keep it out of reach of children, pets, and others.
Daczim-CL P 50mg/31.25mg ...
107
MRP 130
17% off